MYC and fibrosarcoma: In the fibrosarcoma cell line HT-1080, the acute stabilization of the Axin1 protein, sustained by SEN461 treatment, negatively impacts the expression of the proto-oncoprotein c-Myc, an important mediator of sarcoma growth, in vitro and in vivo.